Interactive Stepping Exercise on Executive Function and Gait Variability

September 8, 2018 updated by: Yea-Ru Yang, National Yang Ming University

Effects of Interactive Stepping Exercise on Executive Function and Gait Variability in Community-dwelling Older Adults

The present study is to examine the effects of interactive stepping exercise on executive function and gait variability in community-dwelling older adults

Study Overview

Detailed Description

This is a single blinded, randomized controlled trial. 40 community-dwelling older adults will be recruited and randomly assigned to either experimental group (n=20) or control group (n=20). The 12-week intervention comprises of 1-hour exercise per day and 3 days per week. The experimental group will receive interactive stepping exercise while the control group will be put under home exercise program. Primary outcome measures are executive function and gait variability. Secondary outcome measures include community walking test and other gait parameters (gait velocity, stride length and stride time). The participants will receive assessment at pre- and post-intervention

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beitou
      • Taipei, Beitou, Taiwan, 112
        • Recruiting
        • National Yang-Ming University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 100 years (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • community-dwelling older adults
  • age ≥ 65 years old
  • able to walk independently outdoor without an assistive device
  • Mini-mental state examination ≥ 24
  • use an exercise pre-participation health screening form by the American College of Sports Medicine to recruit those participants that are suitable to join the training session

Exclusion Criteria:

  • diagnosed of any psychiatric and neurologic disorders such as schizophrenia, stroke, Parkinson, Alzheimer disease, etc.
  • any comorbidity or disability that would preclude training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Interactive Stepping Exercise

Interactive Stepping Exercise (1 hour, 3 times/week, 12 weeks)

The 1-hour training program will start with10 minutes warm-up session, after that 40 minutes of ISE, and ended with 10 minutes of cool down session.

Interactive Stepping Exercise (ISE) will perform on a thin mat that was partitioned into 24 squares. The ISE program included forward, backward, lateral and oblique steps, and step patterns were progressively made more complicated.

Interactive Stepping Exercise will perform on a thin mat, stepping pattern will display through a monitor screen, immediate auditory feedback will give for adjustment
ACTIVE_COMPARATOR: Home exercise program
60 minutes, 3 times/week, 12 weeks of home exercise
Home exercise program includes stretching exercise, general strengthening exercise on lower extremity muscles, posture control and balance exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trail Making Test
Time Frame: Change from Baseline at 12 weeks
Executive Function
Change from Baseline at 12 weeks
Stroop Test
Time Frame: Change from Baseline at 12 weeks
Executive Function
Change from Baseline at 12 weeks
Digit Span Test
Time Frame: Change from Baseline at 12 weeks
Executive Function
Change from Baseline at 12 weeks
Executive Interview 25 questions
Time Frame: Change from Baseline at 12 weeks
Executive Function
Change from Baseline at 12 weeks
Gait Variability
Time Frame: Change from Baseline at 12 weeks
Stride length and Stride time variability
Change from Baseline at 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait velocity
Time Frame: Change from Baseline at 12 weeks
Gait speed
Change from Baseline at 12 weeks
Stride length
Time Frame: Change from Baseline at 12 weeks
The distance covered by the combined step length of each limb during gait
Change from Baseline at 12 weeks
Stride time
Time Frame: Change from Baseline at 12 weeks
The time elapsed between the first contact of two consecutive footsteps of the same foot
Change from Baseline at 12 weeks
Functional Ambulation in community
Time Frame: Change from Baseline at 12 weeks
Walk for 400 m distance in community
Change from Baseline at 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 5, 2018

Primary Completion (ANTICIPATED)

July 31, 2019

Study Completion (ANTICIPATED)

July 31, 2019

Study Registration Dates

First Submitted

July 29, 2018

First Submitted That Met QC Criteria

August 3, 2018

First Posted (ACTUAL)

August 8, 2018

Study Record Updates

Last Update Posted (ACTUAL)

September 11, 2018

Last Update Submitted That Met QC Criteria

September 8, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • YM107053F

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Service for the Aged

Clinical Trials on Interactive Stepping Exercise

Subscribe